Gefitinib Innovis

Gefitinib is an oral medication used to treat certain types of cancer. This targeted therapy works by inhibiting specific proteins that contribute to cancer cell growth.

Gefitinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It targets cancer cells with specific genetic mutations, helping to slow or stop their growth. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to interfere with the growth and spread of cancer cells.

Common effects of Gefitinib may include skin rash, diarrhea, and fatigue. Some users also report nausea and loss of appetite. These effects can vary in severity and may not affect everyone who takes the medication.

Gefitinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women and individuals with certain medical conditions should consult a healthcare provider before taking Gefitinib.

Gefitinib may interact with other medications, including those that affect liver enzymes. It is advisable to inform a healthcare provider about all current medications to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Gefitinib.